Birmingham Experimental Cancer Medicine Centre

Jointly funded by Cancer Research UK and the National Institute for Health Research (NIHR), the Birmingham Experimental Cancer Medicine Centre (ECMC) was originally established in 2007 and renewed in 2017 until 2022. In August 2019 Professor Gary Middleton was appointed Director of the Birmingham ECMC, replacing Professor Dion Morton.

Also in 'Birmingham Experimental Cancer Medicine Centre'